Related Experiment Video
Updated: May 26, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Hemolysis upon intravenous immunoglobulin transfusion
1The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6. rpadmore@ottawahospital.on.ca
Summary
High-dose intravenous immunoglobulin (IVIG) can cause hemolysis, particularly in non-O blood group individuals with inflammation. This adverse effect involves antibodies in IVIG and may be preventable with specific strategies.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Intravenous immunoglobulin (IVIG) is a critical therapeutic agent across various medical conditions.
- Hemolysis is a rare but significant adverse effect associated with IVIG administration.
- Understanding the mechanisms and risk factors for IVIG-related hemolysis is crucial for patient safety.
Purpose of the Study:
- To elucidate the underlying mechanisms of IVIG-related hemolysis.
- To identify key risk factors contributing to this adverse event.
- To explore strategies for mitigating IVIG-induced hemolysis.
Main Methods:
- Review of existing literature on IVIG-related hemolysis.
- Analysis of proposed pathophysiological mechanisms, including antibody-mediated and complement-dependent pathways.
- Identification of patient-specific and treatment-related risk factors.
Main Results:
- IVIG-related hemolysis is associated with anti-A and anti-B hemagglutinins present in IVIG products.
- High-dose IVIG in non-O blood group recipients with underlying inflammation represents a significant risk.
- A "two-hit" mechanism with a threshold effect is proposed to explain the development of hemolysis.
Conclusions:
- IVIG-related hemolysis is a complex process involving immune and complement-mediated pathways.
- Risk stratification and targeted interventions can help prevent this adverse event.
- Awareness of risk factors and proposed mechanisms can guide clinical practice and improve patient outcomes.
Related Concept Videos
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:36Humoral Immune Responses
Overview
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...